4.7 Article

Design, synthesis and antitubercular potency of 4-hydroxyquinolin-2(1H)-ones

Journal

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 138, Issue -, Pages 491-500

Publisher

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2017.06.061

Keywords

Mycobacterium tuberculosis; Tuberculosis; 4-Hydroxyquinolin-2(1H)-ones; Antibiotic; Cytotoxicity; Genotoxicity

Funding

  1. Research Foundation Flanders (FWO-Vlaanderen) [12N5915N]
  2. Brazilian Federal Agency
  3. Evaluation of Graduate Education (CAPES) within the Ministry of Education of Brazil [11912/13-8]
  4. Slovenian Research Agency [P1-0230]
  5. TBU in Zlin [IGA/FT/2017/005]

Ask authors/readers for more resources

In this study, a 50-membered library of substituted 4-hydroxyquinolin-2(1H)-ones and two closely related analogues was designed, scored in-silico for drug likeness and subsequently synthesized. Thirteen derivatives, all sharing a common 3-phenyl substituent showed minimal inhibitory concentrations against Mycobacterium tuberculosis H37Ra below 10 mu M and against Mycobacterium bovis AN5A below 15 mu M but were inactive against faster growing mycobacterial species. None of these selected derivatives showed significant acute toxicity against MRC-5 cells or early signs of genotoxicity in the Vitotox (TM) assay at the active concentration range. The structure activity study relation provided some insight in the further favourable substitution pattern at the 4-hydroxyquinolin-2(1H)-one scaffold and finally 6-fluoro-4-hydroxy-3-phenylquinolin-2(1H)-one (38) was selected as the most promising member of the library with a MIC of 3.2 mu M and a CC50 against MRC-5 of 67.4 mu M. (C) 2017 Elsevier Masson SAS. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available